|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
ES2096590T3
(es)
|
1989-06-29 |
1997-03-16 |
Medarex Inc |
Reactivos biespecificos para la terapia del sida.
|
|
US5670617A
(en)
|
1989-12-21 |
1997-09-23 |
Biogen Inc |
Nucleic acid conjugates of tat-derived transport polypeptides
|
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
|
DE69120146T2
(de)
|
1990-01-12 |
1996-12-12 |
Cell Genesys Inc |
Erzeugung xenogener antikörper
|
|
WO1996033735A1
(en)
|
1995-04-27 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
ATE158021T1
(de)
|
1990-08-29 |
1997-09-15 |
Genpharm Int |
Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
WO1992020373A1
(en)
|
1991-05-14 |
1992-11-26 |
Repligen Corporation |
Heteroconjugate antibodies for treatment of hiv infection
|
|
WO1993008829A1
(en)
|
1991-11-04 |
1993-05-13 |
The Regents Of The University Of California |
Compositions that mediate killing of hiv-infected cells
|
|
ES2301158T3
(es)
|
1992-07-24 |
2008-06-16 |
Amgen Fremont Inc. |
Produccion de anticuerpos xenogenicos.
|
|
DK0752248T3
(da)
|
1992-11-13 |
2000-11-13 |
Idec Pharma Corp |
Terapeutisk anvendelse af kimæriske og radioaktivt mærkede antistoffer mod humant B-lymfocytbegrænset differentieringsantig
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
ATE365808T1
(de)
|
1995-07-28 |
2007-07-15 |
Marie Curie Cancer Care |
Transportproteine und deren verwendungen
|
|
JP3295431B2
(ja)
|
1995-10-24 |
2002-06-24 |
サングスタット メディカル コーポレイション |
抗アルファ−ガラクトシルスクリーニング技術
|
|
US5965703A
(en)
|
1996-09-20 |
1999-10-12 |
Idun Pharmaceuticals |
Human bad polypeptides, encoding nucleic acids and methods of use
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
EP1015578A4
(en)
|
1997-09-17 |
2004-12-01 |
Walker And Eliza Hall Inst Of |
THERAPEUTIC MOLECULES
|
|
US20020029391A1
(en)
|
1998-04-15 |
2002-03-07 |
Claude Geoffrey Davis |
Epitope-driven human antibody production and gene expression profiling
|
|
EP1210098A1
(en)
|
1999-04-07 |
2002-06-05 |
Thomas Jefferson University |
Enhancement of peptide cellular uptake
|
|
AU6906100A
(en)
|
1999-08-16 |
2001-03-13 |
Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The |
Receptor-mediated uptake of an extracellular bcl-xl fusion protein inhibits apoptosis
|
|
WO2002020568A2
(en)
|
2000-09-06 |
2002-03-14 |
Abbott Laboratories |
Mutant peptides derived from bad and their use to identify substances which bind to a member of the bcl-2 family of proteins
|
|
WO2002069995A2
(en)
|
2001-02-16 |
2002-09-12 |
Medical College Of Georgia Research Institute, Inc. |
Use of trail and antiprogestins for treating cancer
|
|
WO2003040168A2
(en)
|
2001-11-06 |
2003-05-15 |
Enanta Pharmaceuticals, Inc. |
Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
|
|
WO2003055515A1
(en)
|
2001-12-21 |
2003-07-10 |
Arius Research, Inc. |
Individualized anti-cancer antibodies
|
|
US20040171809A1
(en)
|
2002-09-09 |
2004-09-02 |
Korsmeyer Stanley J. |
BH3 peptides and method of use thereof
|
|
WO2004058804A1
(en)
|
2002-12-24 |
2004-07-15 |
Walter And Eliza Hall Institute Of Medical Research |
Peptides and therapeutic uses thereof
|
|
EP1608969A4
(en)
|
2003-03-19 |
2007-06-06 |
Alfa Wassermann Inc |
SEPARATION AND ACCUMULATION OF SUB-CELLULAR COMPONENTS, AND PROTEINS WHICH ARE DRAWN THEREFROM
|
|
ES2586387T3
(es)
|
2003-11-05 |
2016-10-14 |
Dana-Farber Cancer Institute, Inc. |
Péptidos alfa helicoidales adecuados para activar o inhibir la muerte celular
|
|
WO2006069186A2
(en)
*
|
2004-12-22 |
2006-06-29 |
The Ohio State Research Foundation |
Small molecule bcl-xl/bcl-2 binding inhibitors
|
|
JP2005130867A
(ja)
|
2005-02-16 |
2005-05-26 |
Mitokor |
ミトコンドリア内カルシウムを使用するスクリーニングアッセイ
|
|
WO2006099667A1
(en)
|
2005-03-21 |
2006-09-28 |
The Walter And Eliza Hall Institute Of Medical Research |
Prophylactic and therapeutic agents and uses therefor
|
|
US20070027175A1
(en)
|
2005-07-27 |
2007-02-01 |
Shaughnessy John Jr |
Antineoplastic activities of ellipticine and its derivatives
|
|
CA2645853A1
(en)
|
2006-03-31 |
2007-11-01 |
Dana-Farber Cancer Institute |
Methods of determining cellular chemosensitivity
|
|
US8518635B2
(en)
|
2006-06-12 |
2013-08-27 |
The J. David Gladstone Institutes |
Regulation of protein activity by reversible acetylation
|
|
KR100786759B1
(ko)
|
2006-07-07 |
2007-12-18 |
김현기 |
Ｈｃｃｒ-1을 포함하는 유방암 예후 마커 및 비만 유도조성물
|
|
US9360473B2
(en)
*
|
2006-08-16 |
2016-06-07 |
Eutropics Pharmaceuticals, Inc. |
Assay system to identify therapeutic agents
|
|
WO2008152405A2
(en)
|
2007-06-15 |
2008-12-18 |
The Queen's University Of Belfast |
Protein complexes comprising bh3 peptides and voltage dependent anion channel (vdac) peptides as well as uses thereof for the treatment of proliferative diseases
|
|
JP2011501731A
(ja)
|
2007-09-10 |
2011-01-13 |
ユニバーシティ オブ マサチューセッツ |
ミトコンドリア標的化抗腫瘍剤
|
|
CA2700925C
(en)
|
2007-09-26 |
2016-08-23 |
Dana Farber Cancer Institute |
Methods and compositions for modulating bcl-2 family polypeptides
|
|
JP2009240173A
(ja)
|
2008-03-28 |
2009-10-22 |
Univ Of Tokushima |
パーキン蛋白の新規糖化因子
|
|
MX2011013385A
(es)
|
2009-06-11 |
2012-05-29 |
Minerva Biotechnologies Corp |
Metodos para cultivar celulas madre y celulas progenitoras.
|
|
WO2010147961A1
(en)
|
2009-06-15 |
2010-12-23 |
Precision Therapeutics, Inc. |
Methods and markers for predicting responses to chemotherapy
|
|
US20130122492A1
(en)
|
2011-11-14 |
2013-05-16 |
Kellbenx Inc. |
Detection, isolation and analysis of rare cells in biological fluids
|
|
US20150301053A1
(en)
*
|
2012-05-10 |
2015-10-22 |
Eutropics Pharmaceuticals, Inc. |
Surrogate functional diagnostics test for cancer
|
|
US20150322479A1
(en)
|
2012-06-20 |
2015-11-12 |
Cytospan Technologies Corporation |
Apparatus and method for quantification of replicative lifespan and observation of senescene
|
|
JP6352924B2
(ja)
|
2012-09-19 |
2018-07-04 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
ダイナミックｂｈ３プロファイリング
|
|
JP6327662B2
(ja)
|
2012-09-26 |
2018-05-23 |
学校法人藤田学園 |
細胞表面タンパクを抗原とする抗体を測定する方法
|
|
EP3022222A4
(en)
|
2013-07-18 |
2017-06-07 |
Eutropics Pharmaceuticals, Inc. |
Differential bh3 mitochondrial profiling
|
|
AU2014323526B2
(en)
|
2013-09-19 |
2020-07-23 |
Dana-Farber Cancer Institute, Inc. |
Methods of BH3 profiling
|
|
EP3288964B1
(en)
*
|
2015-04-27 |
2024-02-21 |
Dana-Farber Cancer Institute, Inc. |
High throughput bh3 profiling: a rapid and scalable technology to bh3 profile on low numbers of cells
|
|
US11092602B2
(en)
|
2015-07-06 |
2021-08-17 |
Whitehead Institute For Biomedical Research |
Methods and compositions relating to proteasome inhibitor resistance
|
|
EP3931563A4
(en)
|
2019-02-26 |
2022-12-21 |
Dana-Farber Cancer Institute, Inc. |
BH3 DYNAMIC PROFILING FOR LIVING CELL IMAGING
|